You are here

Geralyn Ritter

Geralyn Ritter and her family have longstanding ties to Summit County, having made it their home-away-from-home for over 50 years.  She joined the Domus Pacis Family Respite board in 2020, inspired by the mission of the organization and by her own medical crisis and recovery experience after a life-changing accident. 

Geralyn is currently a senior executive at Merck & Co., Inc., and has been appointed Executive Vice President and Head of External Affairs and Corporate Governance at Organon & Co., a subsidiary of Merck scheduled to spin out as an independent publicly traded company in 2021.  Ms. Ritter previously served as Senior Vice President Global Public Policy and Corporate Responsibility at Merck and as the company’s Corporate Secretary from 2012-2020.  She also served as President of the Merck Foundation, and led the creation of Merck for Mothers, a $500M global initiative to end maternal mortality.  Earlier in her career, Ms. Ritter led international policy and advocacy programs at PhRMA, worked at the Office of the U.S. Trade Representative as a trade negotiator for the U.S. Government, and advised clients at the D.C. law firm of Covington & Burling.

Geralyn has a J.D. from Stanford Law School, an M.A. in international economics and European politics from Johns Hopkins School of Advanced International Studies and earned her undergraduate degree from Duke University. 

Ms. Ritter co-chairs the Patient and Family Advisory Council at Penn Presbyterian Medical Center and is the author of a forthcoming book on trauma recovery.  She serves on the boards of several other educational and non-profit organizations, including the Sanford School of Public Policy at Duke University, Business for Social Responsibility and Power to Decide.  She is a member of Flemington Presbyterian Church in Flemington, New Jersey.

Geralyn has been married to her husband Jonathan for over 20 years, and they have three sons, Austin, Bradley and Steven.

 

Job Title: 
Senior Executive
Location: 
New Jersey
Company: 
Merck & Company, Inc.